new drug application - Search News

FDA Clears Investigational New Drug Application for REC-4539 in SCLC

The FDA cleared the investigational new drug application for REC-4539, allowing for the start of a phase 1/2 trial in small cell lung cancer and other solid tumor indications.

Cure Today · 4d

FDA Accepts New Drug Application For Taletrectinib in ROS1+ NSCLC

The FDA has granted priority review to an NDA for taletrectinib in the treatment of advanced ROS1-positive non–small cell lung cancer.

Business Insider · 9d

Corcept Therapeutics submits relacorilant new drug application to FDA

Corcept Therapeutics (CORT) has submitted a new drug application to the FDA for its proprietary, selective cortisol modulator, relacorilant, to

MarketWatch · 1d

Solid Biosciences Gains FDA Clearance for New Drug Application

Solid Biosciences received clearance from the Food and Drug Administration for an investigational new drug application, the company said Tuesday. The application is for SGT-212, designed to treat the degenerative disease Friedreich's ataxia.

TipRanks on MSN · 1d

Solid Biosciences gains 12% to $4.40 on FDA clearance of SGT-212 IND

EST Solid Biosciences (SLDB) gains 12% to $4.40 on FDA clearance of SGT-212 IND Published first on TheFly – the ultimate source for

JD Supra23h

Balancing Safety and Accessibility: FDA Broadens Approval Pathway for Nonprescription Drugs by Finalizing the ‘ACNU’ Rule

The US Food and Drug Administration (FDA) has announced a final rule expanding the approval pathway for nonprescription drug ...

Zacks.com on MSN8d

Corcept Submits Application for Another Cushing's Syndrome Drug

Corcept Therapeutics Incorporated CORT recently announced the submission of a new drug application (NDA) to the FDA for its ...

Healio1d

FDA grants priority review to oral non-small cell lung cancer drug

The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with ...

MarketWatch9d

Corcept Therapeutics Submits New Drug Application for Cushing's Sydrome Treatment

Corcept Therapeutics submitted a new drug application to the Food and Drug Administration for its treatment of hypercortisolism, or Cushing's syndrome, a hormonal disorder that occurs when the ...

Business Wire9d

Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination with Defactinib for the Treatment of R…

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

JD Supra13d

CAFC Decision on Orange Book Listings for Drug/Device Combination Patents

On December 20th, 2024, the Court of Appeals for the Federal Circuit issued an important decision in Teva Branded ...

18h

AMD invests $20M in AI-powered drug discovery company Absci

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

10d

Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma

This NDA submission marks a pivotal moment for Chimerix in our mission to bring this potentially life-altering drug to patients diagnosed with recurrent H3 K27M-mutant diffuse glioma,” said Mike ...

19hon MSN

Vanda asserts FDA review of tradipitant was flawed

Vanda (VNDA) has written a letter to FDA Commissioner Robert Califf asserting that the review of the market application for ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results